Skip to main content

Table 1 Study visits and evaluation schedule

From: Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study

Visit

Baseline

KT

Month 1

Month 2

Pre-randomization Screening

Month 3

Randomization

Month 4

Month 6

Month 9

Month 12

Month 18

Month 24

1

2

3

4

5

6

7

8

9

10

Informed consent

X

         

Clinical and demographic data

X

X

X

X

X

X

X

X

X

X

Pregnancy test

  

X

X

      

Randomization criteria

  

X

X

      

Clinical incidents (hypertension, diabetes, dyslipidemia)

X

X

X

X

X

X

X

X

X

X

Kidney graft biopsy

   

X

     

X

General lab testsa

X

X

X

X

X

X

X

X

X

X

Anti-HLA (DSA) antibodies

   

X

   

X

 

X

Renal function

(CKD-EPI)

 

X

X

X

X

X

X

X

X

X

Proteinuria

 

X

X

X

X

X

X

X

X

X

Urinary chemokines (CXCL9 and CXCL10)

 

X

 

X

 

X

 

X

 

X

Elisa Kits: Klotho, FGF-23 TNF and TWEAK/Fn14

 

X

 

X

 

X

 

X

 

X

Assessment of therapeutic compliance (BAASIC scale)

   

X

   

X

 

X

  1. ablood glucose, Calcium, creatinine, Phosphorus, Hematocrit, Hemoglobin, HDL-Cholesterol, LDL-Cholesterol, parathyroid hormone, tacrolimus levels, Total Cholesterol, triglycerides
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us